Immunisation Against Polioviruses in Developing Countries
1993; Wiley; Volume: 3; Issue: 3 Linguagem: Inglês
10.1002/rmv.1980030305
ISSN1099-1654
Autores Tópico(s)Animal Disease Management and Epidemiology
ResumoReviews in Medical VirologyVolume 3, Issue 3 p. 149-160 Forum Immunisation Against Polioviruses in Developing Countries† T. J. John, T. J. John Department of Microbiology and Virology, Christian Medical College and Hospital., Vellore 632 004, Tamilnadu, IndiaSearch for more papers by this author T. J. John, T. J. John Department of Microbiology and Virology, Christian Medical College and Hospital., Vellore 632 004, Tamilnadu, IndiaSearch for more papers by this author First published: September 1993 https://doi.org/10.1002/rmv.1980030305Citations: 19 † The author's views and recommendations presented in this review do not necessarily reflect those of organisations with which he is associated. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Nathanson, N. (1982). Eradication of poliomyelitis in the United States. Rev. Infect. Dis. 4, 940– 945. 2 Lapinleimu, K. (1984). Elimination of poliomyelitis in Finland. Rev. Infect. Dis. 6, S457– S460. 3 WHO (1988). Global eradication of poliomyelitis by the year 2000. In, Forty-first World Health Assembly, Geneva 2–13 May 1988. Resolutions and decisions annexes. (Resolution WHA 41.28) World Health Organization, Geneva. 4 De Quadras, C. A., Andrus, J. K., Olive, J. M. et al. (1991). Eradication of poliomyelitis: progress in the Americas. Pediatr. Infect. Dis., 10, 222– 229. 5 Patriarca, P. A., Wright, P. F. and John, T. J. (1991). Factors affecting the immunogenicity of oral polio-virus vaccine in developing countries: Review. Rev. Infect. Dis., 13, 926– 931. 6 Patriarca, P. A., Laender, F., Palmeira, G. et al. (1988). Randomised trial of alternative formulations of oral poliovaccine in Brazil. Lancet i, 429– 433. 7 Simoes, E. A. F., Padmini, B., Steinhoff, M. C. et al. (1985). Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency. Am. J. Dis. Child., 139, 977– 980. 8 Schonberger, L. B., Kaplan, J., Kim-Farley, R. et al. (1984). Control of poliomyelitis in the United States. Rev. Infect. Dis. 6, S424– S426. 9 Balraj, V., John, T. J., Thomas, M. and Mukundan, S. (1990). Efficacy of oral poliovirus vaccine in rural communities of North Arcot District. India. Int. J. Epidemiol, 19, 711– 714. 10 Montefiore, D., Jamieson, M. E. and Colland, P. (1963). Trial of type 1 oral poliomyelitis vaccine (Sabin) in Nigerian children. Br. Med. J. i, 1569– 1572. 11 Lee, L. H., Lim, K. A. and Tye, C. Y. (1964). Prevention of poliomyelitis in Singapore by live vaccine. Br. Med. J. i, 1077– 1080. 12 Poliomyelitis Commission, Western Region, Ministry of Health Nigeria. (1966). Poliomyelitis vaccination in Ibadan, Nigeria during 1964 with oral vaccine. Bull. WHO, 34, 865– 876. 13 Drozdov, S. G. and Cockburn, W. C. (1967). The state of poliomyelitis in the world. Proceedings of the First International Conference on Vaccines against Viral and Rickettsial Diseases of Man. Scientific Publications No. 147, pp. 198– 209. Pan American Health Organization, Washington, DC. 14 Feldman, R. A., Holguin, A. H. and Gelfand, H. M. (1964). Oral poliovirus vaccination in children: A study suggesting enterovirus interference. Pediatrics 33, 526– 533. 15 Benyesh-Melnick, M., Melnick, J. L. and Alvarez, R. M. (1960). Poliomyelitis infection rate among Mexican children fed attenuated poliovirus vaccines: A. effect of pre-existing poliomyelitis antibody: B. interfering role of other enteroviruses. in, First International Conference on Live Poliovirus Vaccines, Scientific Publication No. 44, pp. 272– 285. Pan American Health Organization, Washington, DC. 16 John, T. J. (1972). Problems with oral poliovaccine in India. Indian Pediatr., 9, 252– 256. 17 John, T. J. and Jayapal, P. (1972). Oral poliovaccination of children in the tropics. 1. The poor seroconversion rates and the absence viral interference. Am. J. Epidemiol, 96, 263– 268. 18 John, T. J. (1975). Oral poliovaccination of children in the tropics. 2. Antibody response in relation to vaccine virus infection. Am. J. Epidemiol., 102, 414– 421. 19 John, T. J. and Christopher, S. (1975). Oral polio-vaccination of children in the tropics. 3. Intercurrent enterovirus infections vaccine virus take rate and antibody response. Am. J. Epidemiol., 102, 422– 428. 20 Pangi, N. S., Master, J. M. and Dave, K. H. (1977). Efficacy of oral poliovaccine in infancy. Indian Pediatr. 14, 523– 528. 21 Ratnasamy, L., John, T. J. and Jadhav, M. (1973). Paralytic poliomyelitis. Clinical and virological studies. Indian Pediatr. 10, 1443– 1447. 22 Kim-Farley, R. J., Rutherford, G., Lichfield, P. et al. (1984). Outbreak of paralytic poliomyelitis in Taiwan. Lancet ii, 1322– 1324. 23 John, T. J. (1985). Poliomyelitis in Taiwan: Lessons for developing countries (Letter to the Editor). Lancet i, 872. 24 Otten, M. W., Deming, M. S., Jaiteh, K. O. et al. (1992). Epidemic poliomyelitis in the Gambia following the control of poliomyelitis as an endemic disease: I. Descriptive findings. Am. J. Epidemiol., 135, 381– 392. 25 Sutter, R. W., Patriarca, P. A., Brogan, S. et al. (1991). Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet, 338, 715– 720. 26 John, T. J. (1984). Poliomyelitis in India: Prospects and problems of control. Rev. Infect. Dis. 6, S438– S441. 27 John, T. J. (1989). Geographic variation in vaccine efficacy. The polio experience. in, Progress in Vaccinology ed by G. P. Talwar, 2, 61– 66. Springer Verlag, New York. 28 Deming, M. S., Jaiteh, K. O., Otten, M. W. et al. (1992). Epidemic poliomyelitis in the Gambia following control of poliomyelitis as endemic disease: II. Clinical efficacy of trivalent oral polio vaccine. Am. J. Epidemiol., 135, 393– 408. 29 Tulchinsky, T., Abed, Y., Shaheen, S. et al. (1989). A ten-year experience in control of poliomyelitis through a combination of live and killed vaccine in two developing areas. Am. J. Public Health, 79, 1648– 1652. 30 John, T. J. (1976). Antibody response of infants in tropics to five doses of oral polio vaccine. Br. J. Med. 1, 811. 31 John, T. J. (1984). Immunoprophylaxis in poliomyelitis. J. Commun. Dis., 16, 38– 42. 32 John, T. J. (1984). Immune response of neonates to oral polio vaccine. Br. Med. J., 13, 502– 505. 33 Ogra, P. L., Karzon, D. T., Righthand, F. and MacGillivary, M. (1968). Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N. Engl. J. Med., 279, 893– 900. 34 Ghendon, Y. Z. and Sanckoyera, L. I. (1961). Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strain) in persons after naturally and experimentally acquired immunity. Acta Virol. (Praha), 5, 265– 273. 35 Faden, H., Modlin, J. F., Thomas, M. L. et al. (1990). Comparative evaluation with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J. Infect. Dis. 162, 1291– 1297. 36 Albrecht, P., Van Steenis, G., Van Wezel, A. L. and Salk, J. (1984). Standardisation of poliovirus neutralising antibody tests. Rev. Infect. Dis. 6, S540– 544. 37 Selvakumar, R. and John, T. J. (1989). Intestinal immunity to poliovirus develops only after repeated infections in monkeys. J. Med. Virol. 27, 112– 116. 38 John, T. J., Deverajan, L. V. and Balasubramanian, A. (1976). Immunization in India with trivalent and monovalent oral poliovirus vaccines of enhanced potency. Bull. WHO, 54, 15– 117. 39 Kok, P. W., Leeuwenburg, J., Tukei, P. et al. (1992). Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bull. WHO, 70, 93– 103. 40 Onorato, I. M., Modlin, J. F., McBean, A. M. et al. (1961). Mucosal immunity induced by enhanced potency inactivated and oral polio vaccines. J. Infect. Dis. 163, 1– 6. 41 Sulekha, C., Susan, S., Bai, N. S. Suguna et al. (1990). An epidemic of poliomyelitis in southern Kerala. Int. J. Epidemiol., 19, 177– 181. 42 Fox, J. P. (1984). Modes of action of poliovirus vaccines and relation to resulting immunity. Rev. Infect. Dis. 6, S352– S355. 43 John, T. J. and Steinhoff, M. C. (1981). Appropriate strategy for immunization of children in India. 3. Community-based annual pulse immunization. Indian J. Pediatr., 48, 677– 683. 44 John, T. J., Pandian, R., Gadomski, A. et al. (1983). Control of poliomyelitis by pulse immunization in Vellore, India. Br. Med. J., 286, 31– 32. 45 Wyatt, H. V. (1985). Provocation of poliomyelitis by multiple injections. Trans. R. Soc. Trap. Med. Hyg., 79, 355– 358. 46 Sutter, R. W., Patriarca, P. A., Suleiman, A. J. M. et al. (1992). Attributable risk of DPT injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J. Infect. Dis., 165, 444– 449. 47 Oduntan, S. O., Lucas, A. O. and Wenneum, E. M. (1978). The immunological response of Nigerian infants to attenuated and inactivated poliovaccines. Ann. Trop. Med. Parasitol., 72, 111– 116. 48 Krishnan, R., Jadhav, M. and John, T. J. (1983). Efficacy of inactivated poliovirus vaccine in India. Bull. WHO, 61, 689– 692. 49 Simoes, E. A. F., Padmini, B., Steinhoff, M. C. et al. (1985). Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency. Am. J. Dis. Child., 139, 977– 980. 50 Salk, F. E. and Drucker, J. (1988). Non-infectious poliovirus vaccine. in, Vaccines, ed. by S. A. Plotkin and E. A. Mortimer, pp. 158– 181. Saunders, Philadelphia. 51 John, T. J., Selvakumar, R., Balraj, V. and Rajarathinam, A., (1987). Field studies using killed poliovirus vaccine. In, Proceedings of the Third International Seminar on Vaccination in Africa Niger, 1987, pp. 173– 181. Association for the Promotion of Preventive Medicine, Paris. 52 Robertson, S. E., Drucker, J. A., Rovira, E. Z. et al. (1988). Clinical efficacy of a new enhanced potency inactivated poliovirus vaccine. Lancet i, 987– 899. 53 Pierce, N. F. and Reynolds, H. Y. (1975). Immunity to experimental cholera. II. Secretory and humoral antitoxin response to local and systemic toxoid administration. J. Infect. Dis., 131, 383– 389. 54 Svennerholm, A. M., Hanson, L. A., Holingren, J. et al. (1981). Antibody response to live and killed poliovirus vaccines in the milk of Pakistani and Swedish women. J. Infect. Dis., 143, 707– 711. 55 Svennerholm, A. M., Gothefors, L., Sack, D. A. et al. (1984). Local and systemic antibody responses and immunological memory in humans after immunization with cholera B submit by different routes. Bull. WHO, 62, 909– 918. 56 Selvakumar, R. and John, T. J. (1987). Intestinal immunity induced by inactivated poliovirus vaccine. Vaccine 5, 141– 144. 57 Drucker, J. (1991). Poliomyelitis in France. Epidemiology and vaccination status. Pediatr. Infect. Dis. J., 10, 967– 969. 58 Samuel, B. U., Cherian, T., Sridharan, G. et al. (1991). Immune response to intradermally injected inactivated poliovirus vaccine. Lancet, 338, 343– 344. 59 Lasch, E. E., Abed, Y., Abdullah, K. et al. (1984) Successful results of a programme combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza. Rev. Infect. Dis. 6, S467– S470. 60 Orgra, P. L., Faden, H. S., Abraham, R. et al. (1991). Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J. Infect. Dis., 161, 191– 194. 61 Simoes, E. A. F., Selvakumar, R., Balraj, V. and John, T. J. (1988). Antibody response of children to measles vaccine mixed with Diphtheria–Pertussis–Tetanus or Diphtheria–Pertussis–Tetanus–Poliomyelitis vaccine. Am. J. Dis. Child., 142, 309– 311. Citing Literature Volume3, Issue3September 1993Pages 149-160 ReferencesRelatedInformation
Referência(s)